Re-evaluation of risk for Down syndrome by means of the combined test in pregnant women of 35 years or more

Prenatal Diagnosis

Volumn 25, Issue 2, 2005, Pages 133-136

  Centini, Giovanni ^a   Rosignoli, Lucia ^a   Scarinci, Renato ^a   Faldini, Elisa ^a   Morra, Carmina ^a   Centini, Gabriele ^a   Petraglia, Felice ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Amniocentesis; Combined test; Second trimester triple test

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT;

ADULT; AMNIOCENTESIS; ARTICLE; DIAGNOSTIC VALUE; DOWN SYNDROME; FEMALE; FETUS; FETUS ECHOGRAPHY; FETUS KARYOTYPING; GONADOTROPIN BLOOD LEVEL; HIGH RISK PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; MEDICAL DECISION MAKING; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY;

ADULT; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CHROMOSOMES, HUMAN, PAIR 18; DOWN SYNDROME; FEMALE; HUMANS; ITALY; MATERNAL AGE; MEDICAL RECORDS; NECK; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TRISOMY;

EID: 14744279540     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.1036     Document Type: Article

References (24)

1. Adinolfi M, Sherlock J. 2001. Fetal cells in transcervical samples at early stages of gestation. J Hum Genet 46: 99-104.
2. Al-Mufti R, Hambley H, Farzaneh F, Nicolaides KH. 1999. Investigation of maternal blood enriched for fetal cells: role in screening and diagnosis of fetal trisomies. Am J Med Genet 85: 66-75.
3. Bahado-Singh R, Shahabi S, Karaca M, Mahoney MJ, Cole L, Oz UA. 2002. The comprehensive mid-trimester test: high sensitivity Down syndrome test. Am J Obstet Gynecol 185: 803-808.
4. Bromley B, Lieberman E, Benacerraf BR. 2002. Fetal nose one length: a marker for Down syndrome in the second trimester. J Ultrasound Med 21: 1387-1394.
5. CEMAT Group. 1998. Randomised trial to assess safety and fetal outcome of early and mid-trimester amniocentesis. Lancet 351: 242-247.
6. Centini G, Rosignoli L, Kenanidis A, Scarinci R, Petraglia F. 2003. A report of early amniocenteses (13+0-14+6 weeks) and mid-trimester amniocenteses (15+0-18+6 weeks): 10 years experience. J Matern Fetal Neonatal Med 14: 113-117.
7. Cicero S, Curcio P, Papageorghiou A, Sonek J, Nicolaides KH. 2001. Absence of nasal bone in fetuses with trisomy 21 at 11-14 weeks of gestation: an observational study. Lancet 358: 1664-1667.
8. Dommergues M, Audibert F, Benattar C, Champagne C, Gomel V, Frydman R. 2001. Is the routine amniocentesis for advanced maternal age still indicated? Fetal Diagn Ther 16: 372-377.
9. Egan JF, Malakh L, Turner GW, Markenson G, Wax JR, Benn PA. 2001. Role of ultrasound for Down syndrome screening in advanced maternal age. Am J Obstet Gynecol 185: 1028-1031.
10. Langdon Down J. 1866. Observation on an ethnic classification of idiots. Clin Lect Rep Lond Hosp 3: 259-262.
11. Muller F, Thalabard JC, Ngo S, Dommergues M. 2002. Detection and false positive rates of maternal serum markers for Down syndrome screening according to maternal age in women over 35 years of age. A study of the agreement of eight dedicated software packages. Prenat Diagn 22: 350-353.
12. Muller F, Thibaud D, Poloce F, et al. 2002. Risk of amniocentesis in women screened positive for Down syndrome with second trimester maternal serum markers. Prenat Diagn 22: 1036-1039.
13. Pandya P, Kondylios A, Hilbert L, Snijders R, Nicolaides KH. 1995a. Chromosomal defects and outcome in 1,015 fetuses with increased nuchal translucency. Ultrasound Obstet Gynecol 5: 15-19.
14. Pandya P, Snijders R, Johnson S, De Lourdes Brizot M, Nicolaides KH. 1995b. Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation. Br J Obstet Gynaecol 102: 957-962.
15. Rosen DJ, Kedar I, Amiel A, et al. 2002. A negative second trimester triple test and absence of specific ultrasonographic marker may decrease the need for genetic amniocentesis in advanced maternal age by 60%. Prenat Diagn 22: 59-63.
16. Shipp TD, Benaceraff BR. 2002. Second trimester ultrasound screening for chromosomal abnormalities. Prenat Diagn 22: 296-307.
17. Strigini F, Centini G, Cariati E, et al. 1995. Screening biochimico per la trisomia 21 del feto in utero: risultati di uno studio multicentrico nella Regione Toscana. Registro Toscano Difetti Congeniti, New Letter.
18. Valenti C, Schutta EJ, Kehaty T. 1968. Prenatal diagnosis of Down syndrome. Lancet 2(7561): 220.
19. Vintzileos AM, Guzman ER, Smulian JC, Yeo L, Scorza WE, Knuppel RA. 2002. Second-trimester genetic sonography in patient with advanced maternal age and normal triple screen. Obstet Gynecol 99: 993-995.
20. Wald NJ, George L, Smith D, Densem JW, Petterson K. 1996a. Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy. Br J Obstet Gynaecol 103: 407-412.
21. Wald NJ, Kennard A, Hackshaw AK. 1996b. First trimester serum-screening for Down's syndrome. Prenat Diagn 16: 387-391.
22. Wald NJ, Kennard A, Hackshaw A, McGuire A. 1997. Antenatal screening for Down's syndrome. J Med Screen 4: 181-246.
23. Wald NJ, Watt HC, Hackshaw AK. 1999. Integrated screening for Down's syndrome based on tests performed during the first and second trimesters. N Engl J Med 341: 461-467.
24. Watchel S, Elias S, Price J, et al. 1991. Fetal cells in the maternal circulation: isolation by multiparameter flow and confirmation by polymerase chain reaction. Hum Reprod 6: 1466-1469.